| Theme | Appropriate Application of New Guidelines for GI Endoscopy in Patients with Antithrombotics | |
|---|---|---|
| Title | Revised Guidelines Concerning Antiplatelet Agents and Endoscopy | |
| Publish Date | 2014/01 | |
| Author | Satoshi Ono | Center for Epidemiology and Preventive Medicine, Graduate School of Medicine, the University of Tokyo |
| Author | Mitsuhiro Fujishiro | Department of Endoscopy and Endoscopic Surgery, Graduate School of Medicine, the University of Tokyo |
| Author | Kazuhiko Koike | Department of Gastroenterology, Graduate School of Medicine, the University of Tokyo |
| [ Summary ] | The guidelines concerning management of antithrombotic agents in the periendoscopic period developed by the Japan Gastroenterological Endoscopy Society were revised in 2012. These guidelines consider the risks of thromboembolic events during cessation periods more closely than before. These new guidelines allow for remarkable changes, such as permitting invasive endoscopic procedures, such as endoscopic biopsies without cessation of medication and high-risk procedures for patients being administered aspirin or cilostazol. Changes are expected in daily clinical practice for gastrointestinal endoscopy in Japan. However, confusions has arisen for physicians and patients due to major differences between previous guidelines and the new guidelines. We illustrate these outlines and issues related to the new guidelines. | |